EXPRESS Medical Center PC provides the oncologist with the genetic analysis of a cancer patient's sensitivity to chemotherapy*, monoclonal antibodies**, and biological modifiers (alternative/natural substances)***. This provides the oncologist with a more precise, accurate, and extensive arsenal of agents, resulting in the most effective therapeutic patient care plan. For stage I to IIIa cancer patients the material that is needed is only a tissue fragment. The material that is needed to perform our panel of genetic tests is simply 15-25 milliliters of peripheral (whole) blood for patients with stage IIIb and IV cancer. In late stage cancer patients we have found that the metastases are genetically different from the original tumor. And since these metastases can cause severe organ damage and eventual failure, it is vital to isolate and analyze the metastases.

• We isolate the epithelial tumor cells (metastases) from the whole blood.
• The isolated metastatic cancer cells are then grown in a culture.
• Next, the cancer cells are exposed to the various anti-cancer agents (chemotherapy, monoclonal antibodies, and biological modifiers).
• As a result, we are able to conclude which anti-cancer substances are the most effective in killing the cancer cells.
• Additionally, we provide the oncologist with information regarding the cancer's genetic expression, its resistance to certain anti-cancer substances, and also check the bio-availability of the cancer cells.
• The detailed results of our genetic analysis are then sent directly to the patient's oncologist within a period of 10 days.

    This allows the oncologist to rapidly devise a precise and accurate patient care plan when time is of the essence. Based on our genetic analysis of the metastases, the average clinical response (remission) of a patient that followed our indications is above 80%.

* Chemotherapies tested
1. Cytostatics:
   Oxaliplatin, cisplatin, carboplatin, cyclophosphamide, ifoshpamide, trophosphamide, treosulphan, melphalan, CCNU, BCNU, ACNU, mitomycin, procarbazine, dacarbazine, bleomycin, temozolomide, estramustin,bendamustin, doxorubicin, liposomal doxorubicin, epirubicin, daunorubicin, dactinomycin, irinotecan, topotecan, idarubicin, etoposide, mitoxandrone, paclitaxel, docetaxel, vincristin, vinblastin, vinorelbin , taurolidin, 5fluoruracil, uracil-tegafur, raltitrexed, floxuridine, capecitabine, methotrexate, gemcitabine, pemetrexed.


2. Immunological modifier:
   IL-2, IFN, kortisole

  ** Monoclonal Antibodies
3. Inhibitors of growth factors:
   octreotide, suramin sulfate, cetuximab, rituximab,transtuzumab, imatinib mesylate, coxibs, monteleucast, tamoxifen, raloxifen, leprolide, anastrozole


4. Inhibitors of angiogenesis:
   Bevacizumab, thalidomide

  ***Biological Modifiers
5. Inhibitors of resisance mechanism:
   Disulfiram, verapamil, ketoconazol, 5-azacytidine


6. Holistic substances:
   H₂O₂, ascorbic acid , carnivora , misteltoe, quercetin , indol-3-carbinol , c-statin , ukrain , polyMVA, co enzyme Q₁₀, essiac tea, modified citrus pectin, IP6 , pacreatic enzymes, salvestrol, Uncaria Tomentosa, carctol, noni juice, annonaceous acetogenins, caesium chloride, reolysin, amygdalin-B₁₇-, artesunate, maitake, lycopene, curcumin, green tee extract, melatonin, ellagic acid, L-methionine, N-acetyl-cystein, Niacin (Vit.B3), L-carnithine, Vitamin E (tocopherol), superoxide dismutase (SOD) , selenium, aloe vera, IFNa2,cytozyme bovine trahea,acemannan, acai berry, avemar pulvis, AHCC-Active Hexose Correlated Compound, silver 32.